Search clinical trials for: inhibitory CAR

Total 221518 results

First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

Neuroendocrine Tumors
Hunan Cancer Hospital

Not yet recruiting

Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer

Advanced Gastric Cancer
Tang-Du Hospital

Recruiting

Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

Small Cell Lung Cancer (SCLC)

China
Guohui Xu

Recruiting

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma | Apatinib | Camrelizumab | Transarterial Chemoembolization

China
Assistance Publique Hopitaux De Marseille

Not yet recruiting

Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma (MEPENDAX)

Ependymoma | Medulloblastoma
Region Skane
Swedish Lung Cancer Study Group

Recruiting

EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study (ERIS)

Non-Small Cell Lung Cancer

Sweden
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Not yet recruiting

Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype

Intracranial Aneurysms | Antiplatelet Drugs
Merck Sharp & Dohme LLC

Not yet recruiting

A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Metastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma
Wuhan Union Hospital, China

Not yet recruiting

Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma | To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer | Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to...
UNC Lineberger Comprehensive Cancer Center

Not yet recruiting

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel (PANGEA)

Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Basal Cell Neoplasm

United States
Jin Ying

Recruiting

A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer

Small Cell Lung Cancer Limited Stage

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases (LungBrain001)

Adenocarcinoma of Lung Metastatic to Brain
University Medical Center Groningen
Dutch Cancer Society

Not yet recruiting

IMPT Dose Escalation for NSCLC (HyDose) (HyDose)

Carcinoma, Non-Small-Cell Lung

Netherlands
National Cancer Institute (NCI)

Not yet recruiting

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 and ASTX727 With Venetoclax to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
Louisiana State University Health Sciences Center...

Recruiting

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Schizophrenia | Schizophrenia; Psychosis | Apathy

United States
Sun Yat-sen University

Not yet recruiting

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Antibody | Liver Cancer

China
University Medical Center Groningen

Not yet recruiting

Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET ([18F]-olaparib)

Head and Neck Squamous Cell Carcinoma (HNSCC)

Netherlands
Lexicon Pharmaceuticals

Recruiting

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy (SONATA-HCM)

Non-obstructive Hypertrophic Cardiomyopathy | Obstructive Cardiomyopathy, Hypertrophic

United States
Andros Day Surgery Clinic

Recruiting

Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility (RECOS)

Unexplained Infertility

Italy
West China Hospital

Recruiting

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

Locally Advanced Thyroid Gland Carcinoma

China
University Medical Center Groningen

Not yet recruiting

Bleeding in Multiple Myeloma (BiMM)

Multiple Myeloma
Christian Schmidt, MD
Johannes Gutenberg University Mainz

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma (CARMAN)

Mantle Cell Lymphoma

Germany
Yunfeng Cheng
Shanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science... and other collaborators

Recruiting

The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP

Immune Thrombocytopenia With Positive ANA Antibodies

China, Hong Kong, Macau
Yunpeng Liu
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Small Cell Lung Cancer

Small Cell Lung Cancer

China
Yunfeng Cheng
Shanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science... and other collaborators

Recruiting

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

Immune Thrombocytopenia With Positive ANA Antibodies

China, Hong Kong, Macau
Yunfeng Cheng
Shanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science... and other collaborators

Recruiting

The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP

Immune Thrombocytopenia With Positive ANA Antibodies

China, Hong Kong, Macau
Lipomedix Pharmaceuticals Inc.

Recruiting

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Cancer of Pancreas | Cancer of Ovary

Israel
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

Belatacept in Heart Transplantation

Heart Transplant

United States
Sichuan University

Recruiting

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

SCLC, Extensive Stage

China
Hunan Province Tumor Hospital

Not yet recruiting

The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer (RAISE)

Non-small Cell Lung Cancer
Zhejiang Cancer Hospital

Not yet recruiting

A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC

Extensive-stage Small-cell Lung Cancer

China
Zhangzhou Municipal Hospital

Not yet recruiting

A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma

Esophageal Small Cell Carcinoma
Henan Cancer Hospital

Recruiting

Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib

Hepatocellular Carcinoma

China
Peking Union Medical College Hospital

Recruiting

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Immune Thrombocytopenia

China
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Not yet recruiting

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma
Tang-Du Hospital

Not yet recruiting

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

Non-Small Cell Lung Cancer | Anti Angiogenesis

China
Fudan University

Not yet recruiting

HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Universitas Diponegoro

Recruiting

Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes (COAF-HF)

Acute Decompensated Heart Failure

Indonesia
RenJi Hospital

Not yet recruiting

Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves

Anticoagulation
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients (CLAD)

Lung Transplant

United States, Canada
Shanghai Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
MU-JHU CARE
Baylor College of Medicine; University of California, San Francisco; Infectious... and other collaborators

Not yet recruiting

HIV Prevention and Care Interventions for Youth in Uganda (HIPCY)

HIV
Ming-Yuan Chen

Not yet recruiting

Clinical Study of Mitoxantrone Hydrochloride Liposome Combined With PD-1 Blockade in Recurrent or Metastatic NPC

Recurrent or Metastatic Nasopharyngeal Carcinoma
AC Camargo Cancer Center

Recruiting

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (EVENET)

Progression | Neuroendocrine Tumors | Neuroendocrine Tumor of the Lung | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1 | Neuroendocrine Tumor of Pancreas | Neuroendocrine Tumor Carcinoid

Brazil
Centre Hospitalier Universitaire de Saint Etienne

Not yet recruiting

Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma (ProApix)

Multiple Myeloma | Total Knee Replacement

France
Xiangya Hospital of Central South University

Not yet recruiting

Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.

Acute Ischemic Stroke
GlaxoSmithKline
iTeos Therapeutics

Recruiting

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Lung Cancer, Non-Small Cell

Argentina, Belgium, Brazil, Canada, Finland, Germany, Italy, Japan, Mexico, Panama, Spain, Taiwan, Turkey, Poland, Netherlands, Korea, Republic of, France, Greece, Bulgaria, Croatia, Czechia, Estonia, Hong Kong, Hungary, India, Philippines, Portuga... and more
Zhiyong Huang
Hubei Cancer Hospital; Wuhan Union Hospital, China; Renmin Hospital of Wuhan... and other collaborators

Recruiting

Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
University of California, San Francisco
Merck Sharp & Dohme LLC; Astellas Pharma Inc

Not yet recruiting

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Bladder Cancer | Muscle-Invasive Bladder Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8

United States

Search clinical trials for: inhibitory CAR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations